Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-01-08 Sale |
2021-01-12 4:12 pm |
Trillium Therapeutics Inc. | TRIL | Parsons James T. Chief Financial Officer |
8,505 | $15.79 | $134,271 | 5,761 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-03 4:46 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
15,917 | $5.34 | 80,141 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:46 pm |
N/A 2035-01-01 |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
4,287 | $0 | 80,141 (Direct) |
View |
| 2024-06-01 Option Award |
2024-06-03 4:21 pm |
N/A 2034-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
28,472 | $0 | 88,409 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-02 4:39 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
21,428 | $2.8 | 59,937 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:21 pm |
N/A 2033-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
16,968 | $0 | 55,477 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 4:44 pm |
N/A 2032-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
13,222 | $0 | 51,731 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-03 4:21 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
16,773 | $3.58 | 38,509 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-16 4:45 pm |
N/A 2031-07-14 |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
9,393 | $0 | 31,340 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 4:12 pm |
N/A 2026-11-09 |
Trillium Therapeutics Inc. | TRIL | Parsons James T. Chief Financial Officer |
8,505 | $0 | 5,761 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 4:12 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Parsons James T. Chief Financial Officer |
8,505 | $7.2447 | 5,761 (Direct) |
View |
Ownership |
2021-01-04 8:21 pm |
N/A 2030-12-23 |
Trillium Therapeutics Inc. | TRIL | Parsons James T. Chief Financial Officer |
0 | $0 | 469,890 (Direct) |
View |
| 2021-01-01 Option Award |
2021-01-04 4:21 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
7,745 | $8.23 | 21,947 (Direct) |
View |
| 2020-06-01 Option Award |
2020-06-02 4:49 pm |
N/A 2030-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
13,306 | $0 | 27,508 (Direct) |
View |
| 2020-06-01 Option Award |
2020-06-02 4:49 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
8,102 | $4.59 | 27,508 (Direct) |
View |